BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 7897355)

  • 1. HIV-1 Induced Cell-to-Cell Fusion or Syncytium Formation.
    Starling T; Padilla-Parra S
    Results Probl Cell Differ; 2024; 71():319-328. PubMed ID: 37996684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Amino Acid at Position 8 of the Proteolytic Cleavage Site of the Mumps Virus Fusion Protein Affects Viral Proteolysis and Fusogenicity.
    Hüttl S; Hoffmann M; Steinmetzer T; Sauder C; Krüger N
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32907974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition.
    Sheik-Khalil E; Bray MA; Özkaya Şahin G; Scarlatti G; Jansson M; Carpenter AE; Fenyö EM
    BMC Infect Dis; 2014 Aug; 14():472. PubMed ID: 25176034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significant differences in cell-cell fusion and viral entry between strains revealed by scanning mutagenesis of the C-heptad repeat of HIV gp41.
    Diaz-Aguilar B; Dewispelaere K; Yi HA; Jacobs A
    Biochemistry; 2013 May; 52(20):3552-63. PubMed ID: 23621782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 Env-Mediated Cell-Cell Fusion by Lectins, Peptide T-20, and Neutralizing Antibodies.
    Yee M; Konopka K; Balzarini J; Düzgüneş N
    Open Virol J; 2011; 5():44-51. PubMed ID: 21660189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage inhibition of the murine coronavirus spike protein by a furin-like enzyme affects cell-cell but not virus-cell fusion.
    de Haan CA; Stadler K; Godeke GJ; Bosch BJ; Rottier PJ
    J Virol; 2004 Jun; 78(11):6048-54. PubMed ID: 15141003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postbinding events mediated by human immunodeficiency virus type 1 are sensitive to modifications in the D4-transmembrane linker region of CD4.
    Moir S; Perreault J; Poulin L
    J Virol; 1996 Nov; 70(11):8019-28. PubMed ID: 8892926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD4 endocytosis in human immunodeficiency virus infection.
    Pelchen-Matthews A; Clapham P; Marsh M
    J Virol; 1995 Dec; 69(12):8164-8. PubMed ID: 7494343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CD4 in HIV envelope-mediated pathogenesis.
    Siliciano RF
    Curr Top Microbiol Immunol; 1996; 205():159-79. PubMed ID: 8575195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 virion-cell interactions: an electrostatic model of pathogenicity and syncytium formation.
    Callahan L
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):231-3. PubMed ID: 8018384
    [No Abstract]   [Full Text] [Related]  

  • 11. A monoclonal antibody to the gp120-CD4 complex has differential effect on HIV-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Celada F; Düzgüneş N
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():669-79. PubMed ID: 7897355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
    Konopka K; Pretzer E; Düzgünes N
    Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in affinity of anti-CD4 monoclonal antibodies predict their effects on syncytium induction by human immunodeficiency virus.
    Wilks D; Walker L; O'Brien J; Habeshaw J; Dalgleish A
    Immunology; 1990 Sep; 71(1):10-5. PubMed ID: 2210798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies.
    Burkly L; Mulrey N; Blumenthal R; Dimitrov DS
    J Virol; 1995 Jul; 69(7):4267-73. PubMed ID: 7769687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.